Search

everythinglearnresearchcommunity

for

Search:↓

Choose the simplest, most fitting scalp reconstruction method for each patient's unique needs.

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

Both surgical hairline advancement and follicular unit transplantation effectively lower the female hairline, but they differ in speed, scarring, and naturalness of results.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Hair loss is linked to heart disease and metabolic syndrome, and while current treatments vary in effectiveness, more research is needed for better solutions.

The procedure is effective for reducing the forehead despite potential for visible scars.

Cross-linked hyaluronic acid injections effectively rejuvenated upper eyelids, giving a youthful look for over a year.

Coats' Plus is a genetic disorder with eye abnormalities, brain calcification, poor growth, bone and skin issues, and movement disorders.

Facial hair restoration is generally successful and satisfying for patients when done with quality techniques and realistic expectations.

Bimatoprost is safe and effective for improving eyebrow hair.

The lateral brow lift technique is safe, effective, and provides long-lasting results.

LAAM caused developmental toxicity in tolerant rats without causing birth defects.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

Environmental factors like smoking, UV exposure, and poor diet contribute to hair loss and graying, and lifestyle changes can help manage it.

Oral isotretinoína effectively stabilizes frontal fibrosing alopecia.

Microneedling is an effective way to treat hair loss from androgenetic alopecia.

Topical Minoxidil is effective for hair loss after COVID-19.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Platelet-rich plasma injections are an effective treatment for hair loss with minimal side effects.

Sabal serrulata and biomimetic peptides with microneedling reduced hair loss and improved hair thickness in men with balding.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Finasteride effectively treats frontal hair loss with few side effects.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Hydroxychloroquine effectively reduces symptoms of frontal fibrosing alopecia, especially in the first 6 months.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

The study found that Frontal Fibrosing Alopecia affects a broader age range of women and early treatment can help stop hair loss.